Incremental direct expenditure of treating asthma in the United States.
about
Microbes and asthma: the missing cellular and molecular links(Correcting) misdiagnoses of asthma: a cost effectiveness analysis.The impact of adherence and disease control on resource use and charges in patients with mild asthma managed on inhaled corticosteroid agents.Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice.Objective airway monitoring improves asthma control in the cold and flu season: a cluster randomized trial.Economic burden of asthma in Abu Dhabi: a retrospective studyExamining the association between childhood asthma and parent and grandparent asthma status: implications for practice.A matched-cohort evaluation of a bedside asthma intervention for patients hospitalized at a large urban children's hospital.Construction of the Pediatric Asthma Impact Scale (PAIS) for the Patient-Reported Outcomes Measurement Information System (PROMIS).Association of environment and place of birth with asthma in Chinese immigrant children.Aldose reductase inhibition suppresses airway inflammation.Proteinases as molecular adjuvants in allergic airway disease.Direct medical costs of constipation from childhood to early adulthood: a population-based birth cohort studyThe Burden of Asthma in Oman.Interventions to improve outcomes for minority adults with asthma: a systematic review.Health-related quality of life and asthma among United States adolescents.Cost benefits of a peer-led asthma self-management program for adolescents.Genetic ancestry and its association with asthma exacerbations among African American subjects with asthma.Magnesium nebulization utilization in management of pediatric asthma (MagNUM PA) trial: study protocol for a randomized controlled trial.The asthma cost in omanChildhood asthma hospitalizations in the United States, 2000-2009.Disparities in Asthma Care, Management, and Education Among Children With Asthma.Costs Attributable to Overweight and Obesity in Working Asthma Patients in the United States.Functional limitations and workdays lost associated with chronic rhinosinusitis and allergic rhinitisLeukotriene modifiers in the treatment of asthma in children.Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm.Allergology in Europe, the blueprint.Leukotriene receptor antagonists pranlukast and montelukast for treating asthma.Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.National estimates of 30-day readmissions among children hospitalized for asthma in the United States.Impact of standardized clinical assessment and management plans on resource utilization and costs in children after the arterial switch operation.Secondhand Smoke Exposure and Pediatric Healthcare Visits and Hospitalizations.State-level medical and absenteeism cost of asthma in the United States.Asthma education in the student laboratory.How can adherence to asthma medication be enhanced? Triangulation of key asthma stakeholders' perspectives.Prevalence and Costs of Five Chronic Conditions in Children.Tiotropium bromide as add-on therapy to inhaled corticosteroids for treating asthma.Health literacy and asthma management among African-American adults: an interpretative phenomenological analysis.The cost of asthma in KuwaitWhat about your friends? Exploring asthma-related peer interactions.
P2860
Q27003976-2B3F25EB-8333-4F89-880A-F66C4F89F45EQ33909313-B9234B2B-8810-4047-AA3A-28EF5DB1107BQ33966122-3B77F903-B2B4-4E96-BF5E-D5BC908C4324Q34206747-51BC2A3A-7F48-4410-932A-80B66A96086DQ34275296-5B7B3442-E00E-4E31-861F-21DE72569B71Q34393601-2645BFBC-3ACA-4AD6-B9D4-227D3A4ADA95Q34489753-23574819-D974-49F1-9A75-4850E07F7B06Q34587868-DBC400FA-C19E-4C03-96B8-93F807CE50A2Q34994828-E6D5D140-9027-48A8-82EB-4CD6D984CADAQ35010341-34D855C5-F90B-4040-A1B7-45E19C84D6B2Q35011968-3902ACDC-F7C6-430E-93BC-AB5DBA7B0B62Q35435370-44054AAA-1F14-4C6B-82CB-BB22A4CB46A7Q35538358-0D3BBC3A-BAEA-42E7-9363-C3529F29B468Q35670333-F96190C5-8A72-49A1-A981-344F4FCC7C34Q36111129-0B7D722A-5248-422A-8FFF-1795F2737A18Q36112760-24CA81CE-92E2-4ECE-B2B8-3E41CC35E520Q36211598-CC579C56-4E9B-4263-A423-4BA4EFEE59E7Q36438022-E166F42E-CC34-4365-ABFF-E6419E9DED26Q36934378-14E79F2C-3117-46DF-8C72-8835852DC742Q36996226-A9DE7BEE-CF68-4A0B-BE51-CAC5EA3F15C4Q37204930-30D5AE5E-41D5-4E52-B525-D4FA14E6F623Q37207417-CFCDDEA8-0DD8-4DA8-AE86-35B86CF7B530Q37438339-F49F8898-DCD0-404B-8472-DC64477246C4Q37530826-4330F253-1C03-4C8E-95B0-BFD74214D599Q37613312-C40FAB95-AEDD-4F7D-B367-3FD149D651E2Q38118606-4B3D9298-8E20-42A6-A79E-821CCB0E5759Q38140060-D618DF6F-D55F-42A9-8F94-9232622DEA77Q38172278-DC6A0886-688B-4821-BDE7-6EB4C3FFBF0DQ38443941-F538E479-ABED-4D2A-9368-A617F95E3605Q38610244-570D9E87-B970-44EA-8741-3065250FDCCCQ38703034-A7998643-E5A9-4CD9-B165-D165D70A7008Q38770326-BD7B8895-A3BC-42AB-9DC4-2F22FFCFABCAQ39313239-561ADE55-9279-4182-8677-E67BCF00D254Q39518429-3D76373E-3E43-4797-97ED-1A4A558648C8Q39775582-7CA512A4-65C3-4AA8-AFBC-D1A46B5B7167Q39863874-52DEE198-4989-47B7-ACC9-9B7BB1C6DEE3Q41722430-08A730D7-9B23-4330-AC70-4119A8B15F45Q42649546-2CEC2A7C-A874-4F65-8CD4-53380E0E60A3Q42759157-CC208C3B-8044-4928-B4EE-E9AFC0F9C1E2Q45115392-A14B1EC3-9F09-4573-A06C-AC95F84EF019
P2860
Incremental direct expenditure of treating asthma in the United States.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Incremental direct expenditure of treating asthma in the United States.
@en
Incremental direct expenditure of treating asthma in the United States.
@nl
type
label
Incremental direct expenditure of treating asthma in the United States.
@en
Incremental direct expenditure of treating asthma in the United States.
@nl
prefLabel
Incremental direct expenditure of treating asthma in the United States.
@en
Incremental direct expenditure of treating asthma in the United States.
@nl
P2860
P1433
P1476
Incremental direct expenditure of treating asthma in the United States
@en
P2093
Shital Kamble
P2860
P356
10.1080/02770900802503107
P407
P577
2009-02-01T00:00:00Z